Cushing's Disease: Second-Line Management When Transsphenoidal Surgery Does Not Achieve Remission

Cushing's disease — ACTH-dependent Cushing's syndrome arising from a corticotrope (pituitary) tumor — requires a structured escalation pathway when the initial surgical approach does not produce confirmed remission.

Clinical scenario

This protocol applies to patients with Cushing's disease due to a pituitary corticotrope adenoma (ACTH-dependent Cushing's syndrome) whose first-line transsphenoidal adenomectomy was performed but did not result in documented remission, or in whom first-line surgery was not feasible.

First-line therapy — failure condition

The first-line approach — transsphenoidal selective adenomectomy (TSS) of the pituitary corticotrope adenoma performed by an experienced pituitary surgeon — is considered non-curative when remission is not confirmed within 7 days of tumor resection: specifically, when morning serum cortisol or urine free cortisol does not fall to the expected post-surgical low range. This unmet remission target is what escalates care to this second-line protocol.

Second-line approach

For patients with ACTH-dependent Cushing's syndrome in whom TSS was noncurative or not possible, a shared decision-making framework guides selection among several distinct categories of second-line intervention — encompassing repeat surgical, radiation-based, and medical options. Which pathway applies, and the complete evidence-based specification, are contained in the full structured regimen.

Goal: cortisol normalization off medication

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1210/jc.2015-1818

The common causes of CS include intrinsic adrenal gland abnormalities and ACTH secretion from a corticotrope tumor (CD) or from an ectopic tumor (EAS).

We recommend transsphenoidal selective adenomectomy (TSS) by an experienced pituitary surgeon as the optimal treatment for CD in pediatric and adult patients.

In patients with ACTH-dependent Cushing's syndrome who underwent a noncurative surgery or for whom surgery was not possible, we suggest a shared decision-making approach because there are several available second-line therapies (eg, repeat transsphenoidal surgery, radiotherapy, medical therapy, or bilateral adrenalectomy).

View source ↗